{"id":"W2565568829","doi":"10.1182/blood.v104.11.3619.3619","title":"Phase III Evaluation of Once-Daily, Oral Therapy with ICL670 (Exjade®) Versus Deferoxamine in Patients with β-Thalassemia and Transfusional Hemosiderosis.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Deferasirox; Hemosiderosis; Medicine; Deferoxamine; Thalassemia; Randomized controlled trial; Liver biopsy; Beta thalassemia; Pediatrics; Internal medicine; Gastroenterology; Surgery; Biopsy","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001904617,0.0001642323,0.0002904601,0.0000937856,0.00004346355,0.000006713365,0.00003833837,0.0001116631,0.00005694011],"category_scores_gemma":[0.0000196623,0.0001079144,0.00003043666,0.0002670035,0.0001100911,0.0000866652,0.000007397511,0.0001649785,9.370131e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004913233,"about_ca_system_score_gemma":0.000248673,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000143006,"about_ca_topic_score_gemma":0.0001496521,"domain_scores_codex":[0.998688,0.00003961184,0.0002330301,0.0002433843,0.0006035354,0.0001924732],"domain_scores_gemma":[0.9994771,0.00002148427,0.00007347119,0.0001536543,0.0001809993,0.00009324076],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.08214801,0.06054474,0.7209815,0.0002713105,0.001473401,0.0000762874,0.008429149,0.00145964,0.02488827,0.0002051188,0.00008090521,0.0994417],"study_design_scores_gemma":[0.7168787,0.01706881,0.2454578,0.0005276169,0.0009349554,0.00002439683,0.000726591,0.0001385394,0.01783935,0.00004030885,0.00006633652,0.0002966451],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9978954,0.0006292783,0.00001664559,0.0002519106,0.00003200296,0.0007848862,0.000008438487,0.00001832787,0.0003631417],"genre_scores_gemma":[0.9992796,0.0001937205,0.0003459627,0.00004785161,0.00001217738,0.00002574465,0.00006274968,0.00002125198,0.00001093875],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6347306,"threshold_uncertainty_score":0.4400622,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01917739710129839,"score_gpt":0.2702377027777295,"score_spread":0.2510603056764311,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}